UNSPSC 85812219: Introduction of other diagnostic substance into lower gi, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other diagnostic substance into lower gi, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0H7KZ

UNSPSC 85812219 Introduction of other diagnostic substance into lower gi, via natural or artificial opening is a Commodity code that shows minimal recent activity aligned with its nominal scope. The recent state and local opportunities tagged under this code do not reflect lower-gastrointestinal diagnostic procedures. Instead, the opportunities span telehealth platforms, nursing home operations, cancer screening, occupational health services, EMS staffing, employee wellness clinics, recovery services, and opioid-use-disorder treatment—a scatter of health and social services unrelated to GI diagnostics. The code appears to be a labeling artifact in state and local procurement databases rather than an active category for health systems or providers seeking diagnostic imaging or endoscopy services.

The issuing bodies across the recent opportunities include health plans (Inland Empire Health Plan, California), county health authorities (DeKalb County Georgia, Nevada Health Authority, Santa Clara County California, multiple Kansas counties), municipal health systems (San Mateo Medical Center, City of Phoenix, City of Ocala), sheriff's offices (Boulder County Colorado, Seminole County Florida), and state health and human services departments (Colorado, Texas, New Jersey, Illinois). Geographic spread spans California, Georgia, Nevada, Florida, Colorado, Kansas, Texas, and other states, but no concentration pattern emerges around lower-GI diagnostics. The source presents no evidence of state or local procurement activity specifically for the diagnostic substance introduction procedure named in UNSPSC 85812219, and pursuit under this code is not recommended without clarification of actual procurement need.